DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,482,062 | +1.5% | 35,725 | -1.2% | 0.78% | -6.9% |
| Q3 2022 | $9,342,000 | +1.5% | 36,170 | -0.4% | 0.84% | +4.9% |
| Q2 2022 | $9,208,000 | -16.7% | 36,322 | -3.6% | 0.80% | -7.3% |
| Q1 2022 | $11,048,000 | -21.0% | 37,665 | -11.4% | 0.86% | -18.7% |
| Q4 2021 | $13,989,000 | +7.5% | 42,518 | -0.6% | 1.06% | -0.4% |
| Q3 2021 | $13,018,000 | +10.5% | 42,760 | -2.6% | 1.06% | +10.4% |
| Q2 2021 | $11,781,000 | +17.7% | 43,899 | -1.3% | 0.96% | +8.8% |
| Q1 2021 | $10,013,000 | -49.6% | 44,486 | -49.9% | 0.88% | -1.5% |
| Q4 2020 | $19,861,000 | +112.3% | 88,817 | +104.5% | 0.90% | -4.8% |
| Q3 2020 | $9,354,000 | +18.1% | 43,441 | -3.0% | 0.94% | +10.7% |
| Q2 2020 | $7,919,000 | +25.0% | 44,784 | -2.1% | 0.85% | +4.2% |
| Q1 2020 | $6,333,000 | +2.0% | 45,754 | +13.1% | 0.82% | +18.5% |
| Q4 2019 | $6,209,000 | +4.1% | 40,456 | -2.0% | 0.69% | -4.3% |
| Q3 2019 | $5,964,000 | -7.5% | 41,295 | -8.5% | 0.72% | -6.1% |
| Q2 2019 | $6,448,000 | +5.0% | 45,119 | -3.0% | 0.77% | +7.7% |
| Q1 2019 | $6,139,000 | +23.5% | 46,499 | -3.5% | 0.71% | +10.6% |
| Q4 2018 | $4,970,000 | -4.3% | 48,197 | +0.9% | 0.64% | +4.6% |
| Q3 2018 | $5,192,000 | +9.2% | 47,778 | -0.9% | 0.62% | +4.4% |
| Q2 2018 | $4,755,000 | -1.5% | 48,190 | -2.2% | 0.59% | -2.0% |
| Q1 2018 | $4,825,000 | -1.7% | 49,280 | -6.8% | 0.60% | +2.6% |
| Q4 2017 | $4,908,000 | +7.3% | 52,874 | -0.8% | 0.59% | +3.2% |
| Q3 2017 | $4,572,000 | +8.2% | 53,294 | +6.4% | 0.57% | +5.6% |
| Q2 2017 | $4,226,000 | -5.0% | 50,076 | -3.7% | 0.54% | -6.6% |
| Q1 2017 | $4,448,000 | +2.2% | 52,002 | -7.0% | 0.58% | -14.3% |
| Q4 2016 | $4,353,000 | -11.0% | 55,920 | +3514.7% | 0.67% | -8.7% |
| Q3 2016 | $4,893,000 | -5.1% | 1,547 | -97.0% | 0.74% | -8.1% |
| Q2 2016 | $5,158,000 | +5.8% | 51,067 | -0.6% | 0.80% | +2.0% |
| Q1 2016 | $4,876,000 | – | 51,398 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |